WishBone Medical, Inc. and Hospital for Special Surgery (HSS) Collaborate to Develop a Novel Pediatric Total Hip Implant.

 Nick Deeter, CEO signing the agreement with Hospital for Special Surgery (HSS)

Nick Deeter, CEO signing the agreement with Hospital for Special Surgery (HSS)

NEW YORK, NY, March 07, 2018 - WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, entered into a license agreement with the global leader in orthopedic surgery, Hospital for Special Surgery (HSS), for the development of a novel Pediatric Total Hip. The system will be developed to address treatment of juvenile idiopathic arthritis (JIA) patients or young patients with congenital dysplastic hip (CDH) disease.

“We look forward to working with HSS on a Pediatric Total Hip system designed just for kids,” said Nick Deeter, Chairman of the Board and CEO at WishBone Medical; “HSS is the premier musculoskeletal hospital in the world and their expertise and collaboration will be invaluable to develop this technology.”

“HSS’s clinical leadership, biomechanical engineering and innovation expertise together with Wishbone’s experience developing technologies to serve pediatric patients, position us to improve the quality of life of these young patients who do not have many therapeutic options,” said Louis A. Shapiro, president and CEO of HSS. “As an inventor of these technologies, Dr. Mark Figgie, our Chief of the Surgical Arthritis Service at HSS is a leading expert in the field, who along with our biomechanical engineers have a long history in both treating and innovating for this patient population.” Shapiro added.

###

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing. To learn more about WishBone Medical, visit www.WishBoneMedical.com  

For more information, please call Andrew Miclot, Vice-Chairman and President at 574-306-4006 or email CustomerService@WishBoneMedical.com. 

About HSS | Hospital for Special Surgery

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients from 80 countries and performed more than 32,000 surgical procedures. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Innovation Institute was formed in 2015 to realize the potential of new drugs, therapeutics and devices; the global standard total knee replacement was developed at HSS in 1969, and in 2017 HSS made 130 invention submissions (more than 2x the submissions in 2015). The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries. Through HSS Global, the institution is collaborating with medical centers worldwide to advance the quality and value of care and to make world-class HSS care more accessible to more people.

WishBone Medical, Inc. entered into a U.S. distribution agreement with Implanet

implanetlogo.jpg

Warsaw, Indiana, March 6, 2018 - WishBone Medical. Inc. entered into a U.S. distribution agreement with Implanet to distribute the JAZZ implant system to treat spinal pathologies requiring vertebral fusion surgery in the Orthopedic Market.

The first procedure with WishBone Medical surgeons was completed in early 2018. “We are looking forward to expanding our Orthopedic spine products and the JAZZ system is our first product in this market,” said Nick Deeter, Chairman of the Board and CEO at WishBone Medical.

Mr. Deeter added, “WishBone Medical provides innovative implants and instruments in sterile packed, single use disposable kits and the JAZZ implant system is available in these single use kits.”

Ludovic Lastennet, CEO of Implanet said, “This disruptive single use, sterile packed business model of WishBone Medical compliments the Implanet America JAZZ platform of single use, sterile packed products.”

To learn more about WishBone Medical, visit www.WishBoneMedical.com

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, visit www.WishBoneMedical.com or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

About IMPLANET

Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its flagship product, the JAZZ® latest-generation implant, aims to treat spinal pathologies requiring vertebral fusion surgery. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. IMPLANET employs 48 staff and recorded 2017 sales of €7.8 million. For further information, please visit www.implanet.com.

Based near Bordeaux in France, IMPLANET established a US subsidiary in Boston in 2013.

IMPLANET is listed on Euronext™ Growth market in Paris. ALIMP

To learn more about IMPLANET, visit www.Implanet.com

Please contact WishBone Medical at 574-306-4006 or email CustomerService@WishBoneMedical.com for more information.  To learn more about WishBone Medical, visit www.WishBoneMedical.com

WishBone Medical, Inc. Names Andrew J. Miclot as President

300x300_Miclot.jpg

Warsaw, Indiana, January 4, 2018 — WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants in sterile packed, single-use disposable kits, announces that Andrew “Andy” J. Miclot has taken on the role of President and will continue in his role as Vice Chairman and Director on the WishBone Medical Board of Directors.

Mr. Miclot is a seasoned executive with almost 40 years of global Medical Device experience. He has been President and CEO of several Medical Device Companies with executive leadership positions, put together world-class management teams and completed and integrated acquisitions globally. He has had success in early stage and in Fortune 500 companies turning around unprofitable and growing primarily Orthopedic and ENT companies. Early experience included growing sterile packed, single-use, disposable kit Medical Device companies.

He is joining WishBone Medical after turning around Micro Machine as President and CEO, an orthopedic company with offices in Warsaw, IN and Kalamazoo MI.  Recent experience includes General Manager ENT /Senior Vice President and Officer of ArthroCare where he increased annual revenue from flat to three years of double digit growth generating 33% of the revenue and 50% of the profit for the entire company.

Andrew was President/CEO and Director of Ascension Orthopedics delivering 15% increase the first year, after two consecutive years of flat sales. He was Senior Vice President of Orthofix where he propelled revenue by 15% in orthopedics that included trauma and external fixation products.

As Senior Vice President/Officer and IRO, he propelled Symmetry Medical, for over thirteen years, from a $10 million breakeven medical device company to $300 million and was key in the NYSE IPO raising $120 million, surpassing Wall Street expectations and generating $220 million via a secondary offering. Other Medical Device Supplier experience included the Executive Vice President of Micro Technologies.

He was Director of Medical Products at DePuy Orthopedics, driving revenues from $64 to $80 million. Responsibilities included trauma, sports medicine, surgical instruments and customs for spine, knee, shoulder, foot, trauma and hip Products. Prior to DePuy, he had several Marketing and Sales leadership positions at Zimmer for over five years in three Divisions; Patient Care, Hall Surgical and Trauma.

Early experience includes: Vice President of Ulti-Med, disposable products for the US and Asia, Medline, as the youngest Director, disposable textile and Custom Sterile Procedure Trays, DeRoyal, Sales Manager with orthopedic soft goods and Custom Sterile Procedure Trays and American Hospital Supply/Hospitex, Sales Manager that turned around a territory ranked worst of 50 to number three in two years and then promoted to Sales Trainer.

Nick Deeter, WishBone Medical’s Founder, Chairman and CEO commented, “We are delighted       that Andy is joining WishBone Medical as Global President. He has extensive and relevant global leadership experience in Orthopedics and with single-use, sterile Medical Devices and a strong record of success. Andy will also remain as the Vice Chairman and Director of WishBone Medical’s Board of Directors and we appreciate his guidance over the last year.”

Andy currently serves on three Boards; WishBone Medical as Vice Chairman and Director, Micro Machine as Director and Precision Optics as Director (Public Company). Also, he is on two Advisory Boards; Indiana University Arts and Sciences Alumni Board and ODT (Orthopedic Design and Technology). He was one of a small group of Founders in “The Institute of Orthopaedic Enlightenment” started by Knowledge Enterprises. He has been key note speakers and panel discussion leaders at several Orthopedic and ENT conferences.

He has a BA in Speech and Hearing Sciences and an MA in Audiology from Indiana University, and an MBA from Lake Forest Graduate School of Management.

About WishBone Medical, Inc.

WishBone Medical, a Global pediatric orthopedic company, is committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For more information, contact Andrew Miclot, Vice Chairman and President, at 574-306-4006 or email CustomerService@WishBoneMedical.com

WishBone Medical, Inc. Releases Broken Screw Removal and K-Wire Systems

Warsaw, Indiana, January 2, 2018 — WishBone Medical, Inc., a new global pediatric orthopedic company, has announced the official launch of the single-use, sterile packed Broken Screw Removal and K-Wire Systems.  The Broken Screw Removal System is available in three different sizes: 2.7mm, 3.5mm and 4.5mm and is designed to remove broken, stripped and cold-welded screws. 

The K-Wire Systems are available in five different configurations; Pediatric Elbow Combo Kit  (1.6mm & 2.0mm K-Wires), Pediatric Long Bone Combo Kit (2.0mm & 2.5mm K-Wires), Three Pediatric Extremity Combo Kits; Small (0.7mm & 0.9mm K-Wires), Medium (0.9mm & 1.25mm K-Wires) and Large (1.25mm & 1.6mm K-Wires). Each system includes two different sizes of wires, protective pin covers and instruments.                                                                       

Nick Deeter, WishBone Medical’s Founder and CEO added, “The Broken Screw Removal and K-Wire Systems both address current issues that Pediatric Surgeons face with their small patients. They need products that are sterile, easy to find, easy to use and designed for pediatric patients. We strongly believe that having these products readily available in sterile packed, single-use kits will be a game changer in the operating room.”

To learn more about WishBone Medical, visit www.WishBoneMedical.com

About WishBone Medical, Inc.

WishBone Medical, a Global pediatric orthopedic company, is committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For more information, contact Andrew Miclot, Vice Chairman and President, at 574-306-4006 or email CustomerService@WishBoneMedical.com

WishBone Medical Inc. Names Jean-Pierre Capdevielle as Chief Strategy Officer and Board Member

300x300_JPC.jpg

Warsaw, Indiana, December 6, 2017 – WishBone Medical, Inc., a new pediatric orthopedic company in Warsaw, Indiana, announced that Jean-Pierre “JP” Capdevielle has taken on the role of Chief Strategy Officer.  Mr. Capdevielle has also been elected unanimously by the Board of Directors to serve as a Director for WishBone Medical, Inc. As CSO, he will work closely with the Chairman of the Board and CEO, Nick Deeter to grow WishBone Medical’s strategic initiatives.

Mr. Capdevielle is a seasoned executive with over 37 years of international experience and has a successful track record of helping startup companies. His knowledge of the orthopedic industry has lead him to the top of major International Medical Device Companies like, Smith & Nephew and Sofamor Danek/Medtronic to name a few. Mr. Capdevielle has lead multiple teams to the successful launches of sophisticated and innovative devices and systems throughout his years of experience.

Jean-Pierre Capdevielle has an extensive professional resume. In 1979 Mr. Capdevielle founded his first company Medical Hospital Products Ltd in Malta, upon leaving in 1982 he had a team of over 240 employees. In 1988 Mr. Capdevielle joined Smith & Nephew to become their Senior Director of Continental Europe and Managing director of French, German and Spanish Operations. Upon joining Smith & Nephew, Mr. Capdevielle lead to a sales growth of 35% a year from 1989-1992 and contributed in the successful introduction of the GENESIS Modular Knee system across EU.

Upon his resignation from Smith & Nephew in 1993, Mr. Capdevielle joined and worked directly with Ron Pickard, CEO and Chairman of Sofamor Danek. At Sofamor Danek Mr. Capdevielle helped bring in revenue of up to $350 million. From 1993-2006 Mr. Capdevielle was a part of many successful business ventures before starting his current business in 2006: Isortho & ICS Consulting Group. Just within the past 4 years, Mr. Capdevielle has contributed to the success of over 22 companies.

WishBone Medical was founded by Nick Deeter, a leader in Pediatric Orthopedics. WishBone is a pediatric orthopedic company focused on the unmet needs of children suffering from orthopedic issues. WishBone’s commitment is to provide anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits with an emphasis to minimize disease, prevent infection, reduce overall costs for our customers and to achieve the best outcomes for children who are still growing, because kids are not just little adults.

“JP brings an incredible amount of medical device industry experience to our team,” says Nick Deeter, Chairman of the Board and CEO of WishBone Medical.  “We are very glad to have him at WishBone Medical to serve as our Chief Strategy Officer and newly elected Board Member.  We are eager for him to work with the WishBone Medical Team as we take the company into a successful second year of operations.”

Mr. Capdevielle received his M.B.A in International Marketing and Finance programs from Hautes Etudes Commerciales Jouy-en-Josas in 1974 and in 1992 completed the Marketing Executive Program from Columbia University in New York. Mr. Capdevielle currently resides in France and is fluent in over 3 languages. He served in the Military from 1974-1976. Mr. Capdevielle is married with two children and enjoys playing/watching rugby and golf in his free time.

To learn more about WishBone Medical, visit www.WishBoneMedical.com. 

About WishBone Medical, Inc.

WishBone Medical, Inc. is a privately held pediatric orthopedic company offering anatomically-appropriate innovative implants and instrument solutions to pediatric patients and surgeons worldwide.

For further information, visit www.wishbonemedical.com or call Allison McSherry, General Manager at (574)306-4006

WishBone Medical Inc. Names Reese Myers as Vice President of Product Development

 Reese Myers

Reese Myers

Warsaw, Indiana, November 1, 2017 – WishBone Medical, Inc., a new pediatric orthopedic company in Warsaw, Indiana, announced that Reese Myers has taken on the role of Vice President of Product Development. Reese will be responsible for product development and commercialization and will work closely with WishBone’s engineering and marketing departments to coordinate market strategy. He will also collaborate closely with other WishBone Team Members to define the strategic direction of the organization and to drive business growth.

Reese’s career in the medical field began as a Certified Surgical Technologist in 1981 working for the highly-skilled and dedicated team at Ortho Indy, primarily at Methodist Hospital of Indianapolis, where he assisted on a wide variety of orthopedic procedures including sports medicine, spine, joint replacement, trauma, hand, pediatric, and general cases over a twelve-year period. 

After completing a BSME at IUPUI in 1993, Reese began his medical device career in Warsaw as a Design Engineer with Othy – now part of Tecomet.  During more than twenty-three years there, he held numerous positions in Product Development, as Marketing Director for the Symmetry Surgical energy portfolio, and Innovation/Technology management with experience licensing and on-boarding products and technologies from external sources.  Reese holds numerous patents, some of which are assigned to orthopedic OEM companies.

WishBone Medical was founded by Nick Deeter, a leader in Pediatric Orthopedics. WishBone is a Warsaw, Indiana based pediatric orthopedic company focused on the unmet needs of children suffering from orthopedic issues. WishBone’s commitment is to provide anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits with an emphasis to minimize disease, prevent infection, reduce overall costs for our customers and to achieve the best outcomes for children who are still growing, because kids are not just little adults.

“I’m excited to join WishBone Medical’s experienced and dedicated team.  I’m also looking forward to working with surgeons and the WishBone team to develop innovative products that will improve the lives of pediatric patients around the world,” says Reese Myers. “Children are the most vulnerable patients, deserving of the special focus and compassion placed on them by pediatric orthopedic surgeons and caregivers every day.”

“Reese brings a tremendous amount of medical device industry experience to our team,” says Nick Deeter, Chairman of the Board and CEO of WishBone Medical.  “We are very glad to have him at WishBone Medical to serve as our lead on the Product Development team.”

Reese and his wife Mickey reside in rural Whitley County, Indiana. Their son and his family live in Lafayette, Colorado while their daughter and her family live in Columbia City, Indiana.

To learn more about WishBone Medical, visit www.WishBoneMedical.com.

About WishBone Medical, Inc.

WishBone Medical, Inc. is a privately held pediatric orthopedic company offering anatomically-appropriate innovative implants and instrument solutions to pediatric patients and surgeons worldwide.

For further information, visit www.wishbonemedical.com or call Allison McSherry, General Manager at (574)306-4006.

WishBone Medical Adds Bontrager and Weidenbenner to Board

Warsaw, Indiana, October 24, 2017 – The Board of Directors of WishBone Medical recently voted to fill two seats on the Board.  The Board unanimously chose to add Jason Bontrager and Dave Weidenbenner to fill these seats. 

 Jason Bontrager

Jason Bontrager

Mr. Bontrager has been a partner in Jayco, Inc. until the company’s acquisition by Thor Industries. The company was founded by his grandfather in 1968 and was wholly-owned by his family until June 2016. Jason is also a partner and director at L&W Engineering, based in Middlebury, Indiana.  Working within his family's business environment he had the opportunity to work in and manage several departments ranging from Marketing, Product Development, Operations, Engineering and Sales.  Throughout his time working at Jayco, he found his niche to be discovering opportunities and innovation.  As a result of this he had an opportunity to mentor in a Private Equity firm and now represents his interests and those of other members of the Bontrager family.

Mr. Weidenbenner has spent 35 years in the healthcare arena via his employment at Zimmer (now Zimmer Biomet), a worldwide manufacturer/supplier/marketer of orthopedic products for hip, knee, elbow, shoulder joint replacement and trauma.

 Dave Weidenbenner

Dave Weidenbenner

Mr. Weidenbenner served in various hip marketing positions leading to Director Global Hip Marketing responsible for the worldwide hip product portfolio earlier in his career at Zimmer.  From 2004 until 2011, Mr. Weidenbenner served as the SVP of Global Brand Management.  In this position he was responsible for the strategic direction of the company's worldwide portfolio of hip, knee, elbow, and shoulder products.  The job required market assessment and driving consensus agreement with the Americas, Europe, and Asia Pacific regions to maximize the company's global investments. He also served on the company’s Operating Committee for a three-year term.

From 2012 until 2015, Mr. Weidenbenner was the VP of Corporate Programs, Sales, and Services. He was responsible for US sales training, US medical education (for surgeons), and managing the Southeast region of the company's independent sales channel which included 8 distributorships.  He led the development and execution of a new tiered sales training program based upon preexisting orthopedic sales experience.  The sales training technique was changed from didactic to a role play model.

“I am very excited that Jason and Dave committed to serve on the Board of Directors at WishBone Medical,” says Nick Deeter, Chairman of the Board and CEO of WishBone Medical.  “They bring a lot of experience and will fill important rolls within the Board that will add significant shareholder value.”

To learn more about WishBone Medical, visit ww.WishBoneMedical.com.

About WishBone Medical, Inc.

WishBone Medical, Inc. is a privately held pediatric orthopedic company offering anatomically-appropriate innovative implants and instrument solutions to pediatric patients and surgeons worldwide.

For further information, visit www.wishbonemedical.com or call Allison McSherry, General Manager at (574)306-4006.

 

 

 

WishBone Medical Inc. Holds First Shareholders Meeting

Shareholder mtg 3.jpg

Warsaw, Indiana, September 26, 2017 - WishBone Medical held its first shareholder meeting since the founding of the company in January 2017.  Investors, employees and guests were given an overall view of WishBone Medical's fast start at the global headquarters in Warsaw, Indiana. CEO and Founder Nick Deeter was reelected unanimously as Chairman of the Board and CEO, Marlin Stutzman and Mary Wetzel were reelected unanimously as President and Chief Operating Officer respectively by the Board of Directors following the shareholder meeting.  Marlin Stutzman and Mary Wetzel will also remain on the Board of Directors.  Three outside shareholders will continue serving on the WishBone Medical Board of Directors; Andy Miclot, J. Pat Richardson and Lynnette Jackson.

"Our team has been working very hard since the beginning of 2017 and together, we have been able to reach the goals that were set forth when the formation of WishBone Medical started late 2016,” Chairman of the Board and CEO Nick Deeter explains.  “Our Shareholders walked away from our meeting feeling very comfortable knowing that WishBone Medical has set out to accomplish the tasks that the company said it would, including a very aggressive new product launch schedule.”

WishBone Medical's focus is the pediatric orthopedic industry and has rolled out its first product, Exact Osteotomy System, in June 2017, which was within the first six months of operation. WishBone Medical plans to roll out 9 more product systems this year, which is unprecedented for new orthopedic companies. 

Shareholders had the opportunity to meet the team that has been assembled this past year and to learn of the rollout and pipeline for products to come into the marketplace late 2017 and in 2018.

“I have been involved with WishBone Medical as a Director and Advisor since its inception,” says J. Pat Richardson. “WishBone Medical started pushing revenue and eliminating unneeded costs from day one” Pat went on to add, “this fast to market revenue, with a minimal inventory business model, is a paradigm shift in the industry.”

WishBone Medical Inc. continues to grow rapidly in a market that is in desperate need of anatomically appropriate pediatric orthopedic devices in their distribution model of single use sterile pack disposable kits.

To learn more about WishBone Medical, visit www.WishBoneMedical.com. 

About WishBone Medical, Inc.

WishBone Medical, Inc. is a privately held pediatric orthopedic company offering anatomically-appropriate innovative implants and instrument solutions to pediatric patients and surgeons worldwide.

For further information, visit www.wishbonemedical.com or call Allison McSherry, General Manager at (574)306-4006.

 

 

 

WishBone Medical, Inc. Names Gary Barnett as Vice President of Regulatory Affairs

300x300_Barnett.jpg

WishBone Medical, Inc., a new pediatric orthopedic company, announced that Gary Barnett has taken on the role of Vice President of Regulatory Affairs. Barnett will be responsible for leading all aspects of global regulatory affairs, implementation, and communication directly with global regulatory agencies. Gary will also provide guidance to new product development teams and collaborate closely with other WishBone Team Members to define the strategic direction of the organization and to drive business growth.

Mr. Barnett began his orthopedic career in 1983 as an industrial engineer.  He progressed into product development, operations, project management, quality, and regulatory affairs. Gary is an inventor/co-inventor on seven orthopedic device patents.  Gary’s previous experience also included regulatory and quality at another pediatric orthopedic company with Nick Deeter.

“Having worked with Gary in the past, we wanted Gary as part of the WishBone team,” said Nick Deeter, CEO of WishBone Medical, Inc.  “Gary has submitted and received nine FDA clearances specifically for Pediatric Orthopedic devices.  This makes Gary one of the top pediatric device 510(k) submitters in the US.  And with our speed to market, we needed that level of expertise to keep up with our product development team.”

WishBone Medical was founded by Nick Deeter, a leader in Pediatric Orthopedics. WishBone is a Warsaw, Indiana based pediatric orthopedic company focused on the unmet needs of children suffering from orthopedic issues. WishBone’s commitment is to provide anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits with an emphasis to minimize disease, prevent infection, reduce overall costs for our customers and to achieve the best outcomes for children who are still growing, because kids are not just little adults.

“Not only does Gary have the Pediatric Orthopedic background, Gary also has quality and regulatory experience with single-use, sterile-packed, disposable kits,” commented Mary Wetzel, COO of WishBone Medical. “The single use disposable kits are the key to global access of Pediatric medical devices.  With all of Gary’s experience, we couldn’t be more pleased with bringing Gary on board.”

“I’m excited to get back into Pediatric Orthopedics once again,” said Gary Barnett, Vice President of Regulatory Affairs for WishBone Medical. “We have a real cause to treat kids with orthopedic issues and with our single-use disposable kits, we can do that worldwide.” 

Gary holds an Industrial Technology degree and an MBA, both from Ball State University.  Gary has two children, a daughter who is an optometry doctor in Wabash, Indiana, and a son who is an attorney in Chicago, Illinois.